Patient Factors Influencing the Prescribing of Lipid Lowering Drugs for Primary Prevention of Cardiovascular Disease in UK General Practice: A National Retrospective Cohort Study

Open Access

Peer-reviewed

Research Article

Jianhua Wu,

Affiliation Centre for Environmental and Preventive Medicine, Barts and The London School of Medicine and Dentistry, University of London, London, United Kingdom
⨯
Shihua Zhu,

Affiliation School of Public Health and Population Science, University of Birmingham, Birmingham, United Kingdom
⨯
Guiqing Lily Yao,

Affiliation Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom
⨯
Mohammed A. Mohammed,

Affiliation School of Public Health and Population Science, University of Birmingham, Birmingham, United Kingdom
⨯
Tom Marshall

* E-mail: t.p.marshall@bham.ac.uk

Affiliation School of Public Health and Population Science, University of Birmingham, Birmingham, United Kingdom
⨯

Reader Comments (3)

Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Lipids
Is the Subject Area "Lipids" applicable to this article?

Thanks for your feedback.
Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Blood pressure
Is the Subject Area "Blood pressure" applicable to this article?

Thanks for your feedback.
Cardiovascular diseases
Is the Subject Area "Cardiovascular diseases" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Cardiovascular therapy
Is the Subject Area "Cardiovascular therapy" applicable to this article?

Thanks for your feedback.